Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1404 |
|---|---|
| Identifier | NCT04176588 |
| Trial Title | A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderately to Severely Active Ulcerative Colitis |
| Interventions | DRUG: Etrasimod|DRUG: Placebo |
Participant Information
| Sponsor | Everstar Therapeutics Limited |
|---|---|
| City | Xi'an |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2019-09-10 |
|---|---|
| Primary Completion Date | 2025-07-24 |
| Completion Date | 2025-10-24 |